Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. - Wikidata - awgldk - TriplyDB

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.

http://www.wikidata.org/entity/Q42522134

about

Characterization of DNA Methylation in Circulating Tumor Cells Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials Progress in circulating tumor cell capture and analysis: implications for cancer management Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.Circulating Tumor Cells in Early-Stage Breast Cancer.International study on inter-reader variability for circulating tumor cells in breast cancer Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.Circulating tumor cells: from bench to bedside Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression CTC enumeration and characterization: moving toward personalized medicine.Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.Circulating tumour cells: their utility in cancer management and predicting outcomes.Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.Sampling circulating tumor cells for clinical benefits: how frequent?Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report.Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer.Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis.Progress in using circulating tumor cell information to improve metastatic breast cancer therapy Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.Detecting circulating tumor cells: current challenges and new trends.Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma.Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma Monitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?Clinical implications of the detection of circulating tumor cells in breast cancer patients.Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer.Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy?Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.Review: circulating tumor cells in the practice of breast cancer oncology.Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib.Circulating Tumor Cells as Cancer Biomarkers in the Clinic.

P2860

Q26778427-9C6289FA-FFA9-4C71-A308-FD4EDF4AC08D Q26827815-E8BCDA91-CF09-4741-9DD2-17A07428483D Q26827936-BC2DA53C-FE8F-48C6-A9FD-9751AF56C98A Q27025737-87A3830F-D0D5-4745-9B89-838966374437 Q28075850-BF0736C1-1115-4705-B638-5598997D1DED Q31006508-BC249D54-BC81-491E-B818-7E8BBA0619DF Q33579111-BC52D608-D458-477D-A6B6-15D5226C51CF Q33738688-FCF3D0D2-A73F-4312-8D94-ED798A100FFD Q34286198-8F6AAE71-C89A-407D-9638-7CC7FC7D4713 Q34307782-5D7917F9-B04E-4758-81C3-0E369F3295F5 Q34496964-C59422C9-C991-4586-9245-841A9458D355 Q34577724-8F360518-EC7C-4AA1-ABCB-456AACB2BE3C Q34669169-FB6621D3-400F-4FAE-A9C8-5A473BC28C31 Q35001280-E57D5E48-74C8-4903-8DE5-315DBCBE7DF4 Q35076325-1875BA90-EB36-41B9-BA71-5AEA28F83FCF Q35427994-40B98220-2F6C-4AB0-95D3-B8DCD6A73D18 Q35519793-EA32E180-A2A7-432E-90F1-536E26E305AD Q35807183-7EF571A1-1C11-4AFC-8CB4-0FCD3A5DFC60 Q35819611-BE94ECFA-DCCF-4C03-A666-0919C6199D24 Q36070763-117C63B8-12A9-4E86-925D-1DBEBC94A16A Q36072794-C05B00D6-DB6A-44A5-A9DF-64E9A717282A Q36095920-50AEBCF4-0D5A-4C22-9473-02491F7D6576 Q36321612-D3181609-95F4-4711-BF48-11438FA58707 Q36406697-9FC551AD-C55A-4B1F-90A1-EC5914C8726E Q36551186-BA7D493A-9552-4DE8-8094-40A2FEC0BF26 Q36752761-EC4ED51B-4ACE-4CDB-9855-D80C4FAF935A Q36869787-D141CBD4-34AC-4C32-ABE0-1E036CA5C67D Q36915318-4E2539F9-0665-4E0B-9056-51639CB112FB Q36934364-B8A831D9-27CC-4A00-B4A6-4D39474FE020 Q37086254-8BE33568-B402-46C6-B380-B5A969B3B266 Q37090760-5825AB8A-71A3-43E6-BA09-CC711142C8DF Q37622003-E26D10D9-4DD2-416E-9068-F7670A87115C Q37716195-4580243C-F12F-41D5-9B40-A9C2626AEF01 Q37980500-692D70CD-0854-47FD-A7DD-8617B08ECFAC Q38070396-0F7677C5-671E-4AA6-95E9-A9E1FDC7D27F Q38508249-CBA19ADA-363A-455F-B192-38AA5FF56E01 Q38547813-4BF47D45-E929-447C-9930-3276E3B82655 Q38662712-C55B23AE-4B9E-4300-8F13-BD0909E88F15 Q39027480-F2CEA3D5-4E25-431C-BE1B-84561797F80F Q39339875-E9BFE6E5-6ACD-4CD3-9FCF-A95E15517CE5

P2860

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.

http://www.wikidata.org/entity/Q42522134

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Variation of circulating tumor ...... and therapeutic implications.

@en

Variation of circulating tumor ...... and therapeutic implications.

@nl

type

label

Variation of circulating tumor ...... and therapeutic implications.

@en

Variation of circulating tumor ...... and therapeutic implications.

@nl

prefLabel

Variation of circulating tumor ...... and therapeutic implications.

@en

Variation of circulating tumor ...... and therapeutic implications.

@nl

P1433

Q42522134-176D84DA-71DF-461B-8145-6A7BBC239877

P1476

Q42522134-50EC7586-565A-488F-9498-282D2D07EC1C

P2093

Q42522134-0569711C-3DC9-4D18-A9A7-E3BA75D21919

Q42522134-1760415F-C57B-4241-A92A-299312EF7E59

Q42522134-1E90055B-2A87-4ABB-8C9B-0872CD5A4E21

Q42522134-34AB9E8E-F7C6-4C69-959E-568F967A6ABF

Q42522134-359C95DB-FC5D-4E28-BBF4-D06150A41FD7

Q42522134-454E3598-6B32-4CF0-AFDA-89222EE25A0F

Q42522134-4D692104-7DFF-4B42-BB37-85F0A7920163

Q42522134-5856135F-C19A-4B1B-A453-8C16049F92EE

Q42522134-6382CEC5-F2B5-4ACF-B23F-F29E0467A41C

Q42522134-70C3CCF7-AD7F-4A94-AAF7-E8A3794EA898

P304

Q42522134-CFABDB48-AD74-462C-9A23-5EC5DD036206

P31

Q42522134-6FBD1ECB-3C31-4389-AE5A-6F274D99A5A5

P356

Q42522134-70864C78-4DBE-451C-B254-2FF63490092D

P433

Q42522134-52B8256E-B614-4639-AD35-5107263BF3FB

P478

Q42522134-796D0FA9-B6A7-4A5F-9700-7D07AA7E64F2

P577

Q42522134-F82E175D-40B2-47F5-919C-2B6BE6FB8577

P5875

Q42522134-18D2BB75-0306-4D35-B46B-35FBDDC34CEC

P698

Q42522134-0FC40283-7D16-4AE6-80FD-5695B0165457

P356

P1433

Annals of Oncology

P1476

Variation of circulating tumor ...... and therapeutic implications.

@en

P2093

A Goldhirsch

http://www.w3.org/2001/XMLSchema#string

E Botteri

http://www.w3.org/2001/XMLSchema#string

E Munzone

http://www.w3.org/2001/XMLSchema#string

E Verri

http://www.w3.org/2001/XMLSchema#string

F Nolé

http://www.w3.org/2001/XMLSchema#string

I Minchella

http://www.w3.org/2001/XMLSchema#string

L Adamoli

http://www.w3.org/2001/XMLSchema#string

L Zorzino

http://www.w3.org/2001/XMLSchema#string

M Medici

http://www.w3.org/2001/XMLSchema#string

M Salvatici

http://www.w3.org/2001/XMLSchema#string

P304

891-897

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDM558

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5791120

http://www.w3.org/2001/XMLSchema#string

P698

18056915

http://www.w3.org/2001/XMLSchema#string